Annual report
4521.TEDINET S100OG68
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥76.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥75.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥89.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥94.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥98.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥17.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥17.8bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥17.5bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥18.2bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥26.9bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥25.0bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27.9bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥13.9bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥18.7bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥9.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥13.4bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥19.4bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥17.8bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥19.0bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥9.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥13.4bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥165.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥163.3bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥157.9bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥156.0bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥152.4bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥26.9bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥27.1bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥138.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥136.3bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥128.5bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥121.1bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥113.9bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥61.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥63.7bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥74.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥77.3bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥73.3bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥58.6bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥52.7bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥13.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥14.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥27.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥21.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥21.7bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥8.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥10.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥9.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥9.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥251.43 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥347.37 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥494.89 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥445.78 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥470.54 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,642.34 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,555.93 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,301.09 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,049.78 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,824.32 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 83.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.4% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.4% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.7% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.5% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.1% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,164 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 1,215 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 1,268 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,341 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 1,389 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥75.9bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥73.9bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥87.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥92.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥96.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥17.4bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥17.7bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥17.9bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥18.2bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥26.9bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥24.9bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27.7bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥14.2bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥18.6bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥9.9bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥13.4bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥19.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥17.7bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥19.0bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥161.8bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥162.3bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥156.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥154.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥150.8bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥25.2bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥27.4bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥136.6bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥135.0bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥128.7bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥120.9bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥113.8bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥59.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥62.7bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥260.61 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥346.63 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥493.31 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥443.8 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥468.84 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥150 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,611.75 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,521.92 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,306.96 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,045.17 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,821.57 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 84.4% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.1% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.4% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.5% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 45,939,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 45,939,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 45,939,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,439,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 48,439,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,152 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 1,207 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 1,258 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 1,333 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 1,382 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥79.2bn |
| Medicinereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥11.3bn |
| Medicinereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.7bn |
| Medicinereportable segment | employees | at 2022-03-31 | 1164 pure |
| Medicinereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥73.6bn |
| Medicinereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥73.6bn |
| Medicinereportable segment | segment assets | at 2022-03-31 | ¥75.6bn |
| Medicinereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥15.7bn |
| Real Estatereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥508m |
| Real Estatereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥322m |
| Real Estatereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.4bn |
| Real Estatereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.4bn |
| Real Estatereportable segment | segment assets | at 2022-03-31 | ¥10.4bn |
| Real Estatereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥76.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥76.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥86.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥17.1bn |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥81.5bn |
| Medicinereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥2.4bn |
| Medicinereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2.5bn |
| Medicinereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥72.6bn |
| Medicinereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥72.6bn |
| Medicinereportable segment | segment assets | at 2021-03-31 | ¥71.7bn |
| Medicinereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥16.4bn |
| Real Estatereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥287m |
| Real Estatereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥292m |
| Real Estatereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥2.4bn |
| Real Estatereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥2.4bn |
| Real Estatereportable segment | segment assets | at 2021-03-31 | ¥10.2bn |
| Real Estatereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥75.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥75.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥81.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥17.8bn |
| Medicinereportable segment | employees | at 2022-03-31 | 1152 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,676
| Item | Context | Value | Unit |
|---|---|---|---|
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)杏林製薬株式会社 | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)東京都千代田神田駿河台４－６ | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)日本生命保険相互会社 | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１－６－６日本生命証券管理部内 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)科研製薬従業員持株会 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)東京都文京区本駒込２－28－８ | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)一単元(100株)未満の株式 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)科研製薬株式会社 | |
| Address of shareholder treasury shares etc | CurrentYearInstant_Row1Member | Original text (Japanese)東京都文京区本駒込２－28－８ | |
| Share ownership plans for directors and other officers and employees (text) | FilingDateInstant | Text · Plus | |
| Classes of shares etc (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of shareholders meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions by resolution of board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text) | FilingDateInstant | Text · Plus | |
| Disposals or holding of acquired treasury shares (text) | FilingDateInstant | Text · Plus | |
| Dividend policy (text) | FilingDateInstant | Text · Plus | |
| Date of resolution dividends of surplus | FilingDateInstant_Row1Member | 2021-11-04 | |
| Resolution dividends of surplus | FilingDateInstant_Row1Member | Original text (Japanese)取締役会決議 (注) | |
| Date of resolution dividends of surplus | FilingDateInstant_Row2Member | 2022-06-29 | |
| Resolution dividends of surplus | FilingDateInstant_Row2Member | Original text (Japanese)定時株主総会決議 (注) | |
| Overview of corporate governance (text) | FilingDateInstant | Text · Plus | |
| Corporate governance company with corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000HoriuchiHiroyukiMember | Original text (Japanese)代表取締役社長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000HoriuchiHiroyukiMember | Original text (Japanese)堀 内 裕 之 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000HoriuchiHiroyukiMember | 1962-03-21 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00935-000HoriuchiHiroyukiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000HoriuchiHiroyukiMember | Original text (Japanese)(注)４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000TanabeYoshioMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000TanabeYoshioMember | Original text (Japanese)田 邉 芳 男 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000TanabeYoshioMember | 1955-03-24 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00935-000TanabeYoshioMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000TanabeYoshioMember | Original text (Japanese)(注)４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000MatsuuraMasahiroMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000MatsuuraMasahiroMember | Original text (Japanese)松 浦 真 洋 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000MatsuuraMasahiroMember | 1969-08-19 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00935-000MatsuuraMasahiroMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000MatsuuraMasahiroMember | Original text (Japanese)(注)４ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000OhtaMinoruMember | Original text (Japanese)取締役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000OhtaMinoruMember | Original text (Japanese)太 田 実 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00935-000OhtaMinoruMember | 1958-12-19 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E00935-000OhtaMinoruMember | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |